New Alzheimer’s data from Cognition Therapeutics appeared to show an early drug effect, but one that lessened over time.
Cognition presented Phase 2 results from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.